NASDAQ · Agricultural Inputs
Arcadia Biosciences, Inc. (RKDA) Stock
$0.26
-3.40%
NASDAQ: RKDA
Basic Materials
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
GlobeNewswire · Jun 13, 2026
Arcadia Biosciences Raises $4 Million in Private Placement
MT Newswires · Jun 12, 2026
Arcadia Biosciences (RKDA) Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
GlobeNewswire · Jun 12, 2026
Arcadia Biosciences: Q1 Earnings Snapshot
Associated Press · May 14, 2026
Arcadia Biosciences (RKDA) Announces First Quarter 2026 Financial Results and Business Highlights
GlobeNewswire · May 14, 2026
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Insiders Held0.16%
Institutions Held16.01%
Institutions Float Held16.04%
Peer Comparison
About Arcadia Biosciences, Inc.
Arcadia Biosciences, Inc. is led by CEO Thomas J. Schaefer, publicly traded since 2015.
Arcadia Biosciences, Inc. (RKDA) stock trades at $0.26 with a market capitalization of $408956. The stock is valued at a price-to-earnings (P/E) ratio of -0.03, price-to-book of 0.61, price-to-sales of 0.09. Over the past 52 weeks the stock has ranged between $0.22 and $6.71, and currently trades 96.1% below its 52-week high.
On profitability, Arcadia Biosciences, Inc. generates a return on equity (ROE) of -339.85%, return on capital employed of -95.57%, an operating margin of -2.01%, a net profit margin of -234.53%.